Literature DB >> 10187798

The ubiquitin-homology protein, DAP-1, associates with tumor necrosis factor receptor (p60) death domain and induces apoptosis.

M L Liou1, H C Liou.   

Abstract

The tumor necrosis factor receptor, p60 (TNF-R1), transduces death signals via the association of its cytoplasmic domain with several intracellular proteins. By screening a mammalian cDNA library using the yeast two-hybrid cloning technique, we isolated a ubiquitin-homology protein, DAP-1, which specifically interacts with the cytoplasmic death domain of TNF-R1. Sequence analysis reveals that DAP-1 shares striking sequence homology with the yeast SMT3 protein that is essential for the maintenance of chromosome integrity during mitosis (Meluh, P. B., and Koshland, D. (1995) Mol. Biol. Cell 6, 793-807). DAP-1 is nearly identical to PIC1, a protein that interacts with the PML tumor suppressor implicated in acute promyelocytic leukemia (Boddy, M. N., Howe, K., Etkin, L. D., Solomon, E., and Freemont, P. S. (1996) Oncogene 13, 971-982), and the sentrin protein, which associates with the Fas death receptor (Okura, T., Gong, L., Kamitani, T., Wada, T., Okura, I., Wei, C. F., Chang, H. M., and Yeh, E. T. (1996) J. Immunol. 157, 4277-4281). The in vivo interaction between DAP-1 and TNF-R1 was further confirmed in mammalian cells. In transient transfection assays, overexpression of DAP-1 suppresses NF-kappaB/Rel activity in 293T cells, a human kidney embryonic carcinoma cell line. Overexpression of either DAP-1 or sentrin causes apoptosis of TNF-sensitive L929 fibroblast cell line, as well as TNF-resistant osteosarcoma cell line, U2OS. Furthermore, the dominant negative Fas-associated death domain protein (FADD) protein blocks the cell death induced by either DAP-1 or FADD. Collectively, these observations highly suggest a role for DAP-1 in mediating TNF-induced cell death signaling pathways, presumably through the recruitment of FADD death effector.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10187798     DOI: 10.1074/jbc.274.15.10145

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Genetic characterization and fine mapping of susceptibility loci for sarcoidosis in African Americans on chromosome 5.

Authors:  Courtney Gray-McGuire; Ritwik Sinha; Sudha Iyengar; Christopher Millard; Benjamin A Rybicki; Robert C Elston; Michael C Iannuzzi
Journal:  Hum Genet       Date:  2006-08-04       Impact factor: 4.132

2.  DAP1, a negative regulator of autophagy, controls SubAB-mediated apoptosis and autophagy.

Authors:  Kinnosuke Yahiro; Hiroyasu Tsutsuki; Kohei Ogura; Sayaka Nagasawa; Joel Moss; Masatoshi Noda
Journal:  Infect Immun       Date:  2014-09-02       Impact factor: 3.441

3.  TRUSS, a novel tumor necrosis factor receptor 1 scaffolding protein that mediates activation of the transcription factor NF-kappaB.

Authors:  Surinder M Soond; Jennifer L Terry; Jeff D Colbert; David W H Riches
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

4.  Protein kinase Cepsilon inhibits UVR-induced expression of FADD, an adaptor protein, linked to both Fas- and TNFR1-mediated apoptosis.

Authors:  Moammir Hasan Aziz; Kaitlin Elizabeth Sundling; Nancy Ellen Dreckschmidt; Ajit Kumar Verma
Journal:  J Invest Dermatol       Date:  2009-02-05       Impact factor: 8.551

Review 5.  TNF-induced signaling in apoptosis.

Authors:  P C Rath; B B Aggarwal
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.542

6.  Apoptosis gene profiling reveals spatio-temporal regulated expression of the p53/Mdm2 pathway during lens development.

Authors:  Jenny C Geatrell; Peng Mui Iryn Gan; Fiona C Mansergh; Lilian Kisiswa; Miguel Jarrin; Llinos A Williams; Martin J Evans; Mike E Boulton; Michael A Wride
Journal:  Exp Eye Res       Date:  2009-02-11       Impact factor: 3.467

7.  At the crossroads of SUMO and NF-kappaB.

Authors:  Martin P Kracklauer; Christian Schmidt
Journal:  Mol Cancer       Date:  2003-11-05       Impact factor: 27.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.